Literature DB >> 14687742

Dose of GnRH agonist (nafarelin acetate) affects intrafollicular PAPP-A expression in controlled ovarian hyperstimulation cycle.

JiHyun Suh1, EunYoung Lee, SeongSoo Hwang, Sarah Yoon, Byung Koo Yoon, DukSoo Bae, DooSeok Choi.   

Abstract

OBJECTIVE: To determine the effect of dose of GnRH agonist on the follicular environment in controlled ovarian hyperstimulation (COH) cycles. STUDY
DESIGN: Twenty-eight IVF patients with normal ovarian function were divided into three groups: group I received GnRHa (nafarelin acetate/Synarel) intranasally at 200 microg daily, group II received 400 microg daily until hCG injection, and group III was given 400 microg daily before the initiation of ovarian stimulation, then 200 microg daily before the day of hCG injection. Serum estradiol, progesterone, and leptin levels were measured on the day of hCG injection. After aspiration, expression of pregnancy-associated alpha-plasma protein (PAPP)-A in the follicular fluid of dominant follicles (>20 mm) was determined by Western blot analysis.
RESULTS: No significant difference was noted in serum estradiol, progesterone, and leptin levels. But intrafollicular PAPP-A expression was significantly higher in group II compared to other groups (P<0.05).
CONCLUSION: The dose of GnRHa may have an impact on the intrafollicular environment of dominant follicles in COH cycles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687742     DOI: 10.1016/s0301-2115(03)00317-8

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  1 in total

1.  The correlation between follicular fluid pregnancy-associated plasma protein A levels, fertilization, and embryo quality in GnRH agonist and GnRH antagonist protocols in ART cycles.

Authors:  Razieh Dehghani Firouzabadi; Farnaz Mohammadian; Mehri Mashayekhy; Robab Davar; Maryam Eftekhar
Journal:  Iran J Reprod Med       Date:  2012-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.